The Glutamate-Glutamine Cycle in Epilepsy

Area of Science:

• Neuroscience
• Biochemistry
• Pathology

Background:

• Epilepsy is a neurological disorder affecting 70 million worldwide, characterized by recurrent seizures and comorbidities.
• A significant portion of epilepsy patients (up to one-third) are refractory to current antiepileptic medications.
• Dysregulation of the brain's glutamate-glutamine cycle is a common feature in epilepsy.

Purpose of the Study:

• To review alterations in glutamate-glutamine cycle components in epilepsy.
• To discuss potential therapeutic strategies targeting this cycle for epilepsy treatment.

Main Methods:

• Review of scientific literature on epilepsy and the glutamate-glutamine cycle.
• Identification of altered neurotransmitters, metabolites, enzymes, transporters, and receptors in epilepsy.
• Evaluation of potential human-applicable interventions targeting the glutamate-glutamine cycle.

Main Results:

• Key glutamate-glutamine cycle components, including glutamate levels, glutamine synthetase, glutaminase, and glutamate dehydrogenase, are frequently perturbed in epilepsy.
• Alterations involve neurotransmitters, metabolites, enzymes, amino acid transporters, and glutamate receptors.

Conclusions:

• The glutamate-glutamine cycle presents promising targets for novel antiepileptic interventions.
• Therapeutic strategies such as glutamate receptor blockers, glutamate scavenging, dietary changes, and hypothermia warrant further investigation for epilepsy management.